RecruitingNCT04095195
Registry of Subjects at Risk of Pancreatic Cancer
Studying Familial atypical multiple mole melanoma syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Associazione Italiana per lo Studio del Pancreas
- Intervention
- MRCP(radiation)
- Enrollment
- 1000 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2019 – 2045
Study locations (4)
- Istituto Clinico Humanitas, Rozzano, Milan, Italy
- Ospedale Pederzoli, Peschiera del Garda, Verona, Italy
- San Raffele Vita Salute University Hospital, Milan, Italy
- Chirurgia Generale e del Pancreas, Verona, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04095195 on ClinicalTrials.govOther trials for Familial atypical multiple mole melanoma syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06599619Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic NeviJohn Kirkwood
- RECRUITINGNCT05446155BioMEL- Diagnostic and Prognostic Factors in Melanoma.Region Skane
- RECRUITINGNCT00040352Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of MelanomaNational Cancer Institute (NCI)
See all trials for Familial atypical multiple mole melanoma syndrome →